Sfoglia per Rivista VALUE IN HEALTH
Budget Impact Analysis for Peginterferon Beta-1a In Relapsing Remitting Multiple Sclerosis In Italy
2015-11-01 Iannazzo, S; Santoni, L; Saleri, C; Puma, E; Vestri, G; Giuliani, L; Centonze, D; Canonico, P
Cost-Effectiveness Analysis of Peginterferon Beta-1a In Italian Relapsing Remitting Multiple Sclerosis Management
2015-11-01 Iannazzo, S; Santoni, L; Saleri, C; Puma, E; Vestri, G; Giuliani, L; Canonico, P; Centonze, D
Economic Consequences of Anti-HCV Antiviral Treatment Investment from the NHS Perspective
2018-01-01 Mennini, F; Marcellusi, A; Viti, R; Kondili, L; Rosato, S; Vella, S; on behalf of PITER collaboration study group, N
OSTEOPOROSIS COSTS IN ITALY. INTERIM RESULTS OF THE BLOCK STUDY
2010-01-01 Veronesi, C; Adami, S; Iolascon, G; Nardi, A; Pietrogrande, L; Resmini, G; Rossini, M; Tarantino, U; Tranquilli, L; Trevisan, C; Buda, S; Intorcia, M
PCV36 The Future Burden of Heart Disease in Europe, JAPAN, and the United States
2020-01-01 Chapel, J; Hashimoto, H; Kasajima, M; Peneva, D; Van Nuys, K; Atella, V; Belotti, F; Tysinger, B; Piano Mortari, A
PDB39 Assessing the IMPACT of New ANTI Diabetics Drugs: A Dynamic Microsimulation Approach
2020-01-01 Atella, V; Belotti, F; Piano Mortari, A
PIN79 - ECONOMIC CONSEQUENCES OF ANTI-HCV ANTIVIRAL TREATMENT INVESTMENT FROM THE NHS PERSPECTIVE: A REAL-WORLD-BASED ANALYSIS FROM PITER DATA
2018-01-01 Marcellusi, A; Viti, R; Kondili, L; Rosato, S; Vella, S; Mennini, Fs
Validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Summary Score in Patients With Hematologic Malignancies
2019-01-01 Efficace, F; Cottone, F; Sommer, K; Kieffer, J; Aaronson, N; Fayers, P; Groenvold, M; Caocci, G; Lo Coco, F; Gaidano, G; Niscola, P; Baccarani, M; Rosti, G; Venditti, A; Angelucci, E; Fazi, P; Vignetti, M; Giesinger, J
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-nov-2015 | Budget Impact Analysis for Peginterferon Beta-1a In Relapsing Remitting Multiple Sclerosis In Italy | Iannazzo, S; Santoni, L; Saleri, C; Puma, E; Vestri, G; Giuliani, L; Centonze, D; Canonico, P | Articolo su rivista | |
| 1-nov-2015 | Cost-Effectiveness Analysis of Peginterferon Beta-1a In Italian Relapsing Remitting Multiple Sclerosis Management | Iannazzo, S; Santoni, L; Saleri, C; Puma, E; Vestri, G; Giuliani, L; Canonico, P; Centonze, D | Articolo su rivista | |
| 1-gen-2018 | Economic Consequences of Anti-HCV Antiviral Treatment Investment from the NHS Perspective | Mennini, F; Marcellusi, A; Viti, R; Kondili, L; Rosato, S; Vella, S; on behalf of PITER collaboration study group, N | Articolo su rivista | |
| 1-gen-2010 | OSTEOPOROSIS COSTS IN ITALY. INTERIM RESULTS OF THE BLOCK STUDY | Veronesi, C; Adami, S; Iolascon, G; Nardi, A; Pietrogrande, L; Resmini, G; Rossini, M; Tarantino, U; Tranquilli, L; Trevisan, C; Buda, S; Intorcia, M | Articolo su rivista | |
| 1-gen-2020 | PCV36 The Future Burden of Heart Disease in Europe, JAPAN, and the United States | Chapel, J; Hashimoto, H; Kasajima, M; Peneva, D; Van Nuys, K; Atella, V; Belotti, F; Tysinger, B; Piano Mortari, A | Articolo su rivista | |
| 1-gen-2020 | PDB39 Assessing the IMPACT of New ANTI Diabetics Drugs: A Dynamic Microsimulation Approach | Atella, V; Belotti, F; Piano Mortari, A | Articolo su rivista | |
| 1-gen-2018 | PIN79 - ECONOMIC CONSEQUENCES OF ANTI-HCV ANTIVIRAL TREATMENT INVESTMENT FROM THE NHS PERSPECTIVE: A REAL-WORLD-BASED ANALYSIS FROM PITER DATA | Marcellusi, A; Viti, R; Kondili, L; Rosato, S; Vella, S; Mennini, Fs | Articolo su rivista | |
| 1-gen-2019 | Validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Summary Score in Patients With Hematologic Malignancies | Efficace, F; Cottone, F; Sommer, K; Kieffer, J; Aaronson, N; Fayers, P; Groenvold, M; Caocci, G; Lo Coco, F; Gaidano, G; Niscola, P; Baccarani, M; Rosti, G; Venditti, A; Angelucci, E; Fazi, P; Vignetti, M; Giesinger, J | Articolo su rivista |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile